血清衍生连接体指标在识别肝硬化时的可靠性
Jisheng Guo1, Xiaona Wang2, Guangming Li3
1College of Basic Medicine, Yantai Campus of Binzhou Medical University, Yantai 264003, China.
Journal of proteome research
|September 21, 2024
概括
肝硬化病的鉴定至关重要. 一个新的Connectome战略整合了新陈代谢学和蛋白质学,可以准确地区分肝硬化与慢性乙型肝炎以及使用特定生物标志物的健康个体.
科学领域:
- 生物标志物发现发现
- 蛋白质组学和代谢组学整合
- 系统生物学 系统生物学
背景情况:
- 肝硬化带来重大健康风险,需要可靠的诊断方法.
- 目前的诊断方法可能需要改进,以实现早期和准确的检测.
- 整合多omics数据为增强疾病识别提供了一个有希望的途径.
研究的目的:
- 开发和验证一个新的Connectome策略来识别肝硬化.
- 整合代谢和蛋白质组数据,以提高诊断准确度.
- 为了确定区分肝硬化与其他肝脏疾病和健康状态的特定生物标志物.
主要方法:
- 采用Connectome策略,将蛋白质组学中的代谢学和谱匹配 (PSM) 结合起来.
- 利用开放搜索蛋白质组学方法来识别与血液蛋白结合的代谢物.
- 应用部分最小平方区分分析 (PLS-DA),统一多重近似和预测 (UMAP) 和数据分析的层次聚类.
主要成果:
- 鉴定出81种与肝硬化相关的连接体.
- 开发了一个强大的模型,能够区分肝硬化和慢性乙型肝炎 (CHB) 和健康群体,通过PLS-DA,UMAP和等级集群验证.
- 建立了肝硬化统一指标 (包括铁素,Unnamed_189.2, thiazolidine),准确识别了肝硬化病例,并得到了外部数据的进一步证实.
结论:
- 特征性肝硬化连接体可靠地区分肝硬化与CHB和健康个体.
- 开发的"肝硬化统一指标"为识别肝硬化提供了有效的工具.
- 这种综合的多学科方法具有改善肝硬化诊断的巨大潜力.
相关概念视频
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Cirrhosis I: Introduction
Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Cirrhosis II: Pathophysiology
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...


